We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Slowdown in DNA Replication Leads to Cancer-Forming Genomic Damage

By LabMedica International staff writers
Posted on 19 Jul 2011
Print article
In a recent publication, cancer researchers described a mechanism for the formation of breakage in DNA at specific “fragile sites” that induced chromosomal instability, which is characteristic of cells in the early stages of cancer development.

Investigators at the Hebrew University of Jerusalem (Israel) employed sophisticated new methodology that allowed the study of single DNA molecules to study the basis for the formation of breaks at specific fragile sites.

They reported in the July 8, 2011, issue of the journal Molecular Cell that even under normal growth conditions, replication fork progression along the fragile chromosome site, FRA16C, was slow, and forks frequently stalled at adenine-thymine (A-T) rich sequences, leading to activation of additional origins to enable replication completion. Under mild replication stress, the frequency of stalling at A-T-rich sequences was further increased. Unlike in the entire genome, in the FRA16C region additional origins were not activated, suggesting that all potential origins were already activated under normal conditions.

The basis for FRA16C fragility was replication fork stalling at A-T-rich sequences and the inability of the cell to activate additional origins under replication stress. These results provide a mechanism explaining the replication stress sensitivity of fragile sites and thus, the basis for genomic instability during early stages of cancer development.

“A hallmark of most human cancers is accumulation of damage in the DNA, which drives cancer development,” said senior author Dr. Batsheva Kerem, professor of genetics at the Hebrew University of Jerusalem. “In the early stages of cancer development, the cells are forced to proliferate. In each cycle of proliferation, the DNA is replicated to ensure that the daughter cells have a full DNA. However, in these early stages the conditions for DNA replication are perturbed, leading to DNA breaks, which occur specifically in regions defined as ‘fragile sites.’”

Related Links:

Hebrew University of Jerusalem


Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Food Allergens Assay Kit
Allerquant 14G A
New
Urine Bone Markers Control
Lyphochek Urine Bone Markers Control

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.